News

Entire IR Site Press Releases Only Filings Only
ALEXANDRIA REAL ESTATE EQUITIES, INC. (NYSE: ARE)   

Sara Kabakoff
626.788.5578
skabakoff@are.com


Display:
Notify me when new press releases are posted to this site.
News 
DateHeadlineFormat
2/19/2019Alexandria Real Estate Equities, Inc. Upgraded by S&P Global Ratings to BBB+ With Stable Outlook
2/14/2019Alexandria Real Estate Equities, Inc. Earns First-Ever Recognition as Fitwel's #1 Industry Leading Company for Best in Building Health
2/07/2019Alexandria Real Estate Equities, Inc. Expands Its Seattle Life Science Cluster Campuses Through Value-Creation Development of More Than 300,000 RSF and Extension of Alexandria LaunchLabs and Alexandria Seed Capital Platform
2/04/2019Alexandria Real Estate Equities, Inc. Reports: 2018 Revenues of $1.3 billion, up 17.7% over 2017; 4Q18 Loss Per Share - Diluted of $(0.30) and 2018 EPS - Diluted of $3.52; 4Q18 and 2018 FFO - Diluted, As Adjusted, Per Share of $1.68 and $6.60; Operational Excellence and Growing Dividends
1/28/2019Alexandria Real Estate Equities, Inc. Announces Tax Treatment of Year 2018 Distributions
1/07/2019Alexandria Venture Investments Recognized as #1 Most Active Investor in Healthcare Startups
12/18/2018Alexandria Real Estate Equities, Inc. to Present at 37th Annual J.P. Morgan Healthcare Conference
12/14/2018Alexandria LaunchLabs, the Premier Platform Accelerating Early-Stage Life Science Company Growth, Opens First Cambridge Location at the Alexandria Center at One Kendall Square
12/11/2018Alexandria Real Estate Equities, Inc. to Hold Its Fourth Quarter and Year End 2018 Operating and Financial Results Conference Call and Webcast on February 5, 2019
12/03/2018Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 97 Cents per Common Share Up 4 Cents, or 4 Percent, over 3Q18
11/07/2018Alexandria Real Estate Equities, Inc. Announces Development of New Build-to-Suit at the Alexandria Life Science and Translational Research Center at 9800 Medical Center Drive with Signing of 15-Year, 132,000 RSF Lease for REGENXBIO's New HQ and R&D Facility
10/29/2018Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2018, Financial and Operating Results: Strong Internal and External Growth, Operational Excellence and Growing Dividends
10/18/2018Alexandria Real Estate Equities, Inc. Initiates Development of 550,000 RSF North Tower at the Alexandria Center for Life Science - NYC to Expand NYC's First and Only Commercial Life Science Campus Uniquely Designed and Amenitized for Innovative Life Science Companies at All Stages of Development, with Signing of Ground Lease Amendment
9/26/2018Alexandria Real Estate Equities, Inc. Upgraded by Moody's to Baa1 with Stable Outlook
9/12/2018Alexandria Real Estate Equities, Inc. Ranked #1 Globally in the 2018 GRESB Health & Well-being Module, Earns an "A" Disclosure Score and Awarded Green Star in 2018 GRESB Assessment
9/05/2018Alexandria Real Estate Equities, Inc. to Hold Its Third Quarter 2018 Operating and Financial Results Conference Call and Webcast on October 30, 2018
9/04/2018Alexandria Real Estate Equities, Inc. Declares Quarterly Cash Dividend of 93 Cents per Common Share Up 7 Cents, or 8 Percent, over 3Q17
7/30/2018Alexandria Real Estate Equities, Inc. Reports Second Quarter Ended June 30, 2018, Financial and Operating Results Strong Internal and External Growth, Operational Excellence and Growing Dividends
7/18/2018Alexandria Real Estate Equities, Inc. Releases Inaugural Corporate Responsibility Report, Unveils 2025 Sustainability Goals and Issues First Green Bond
7/13/2018Alexandria Real Estate Equities, Inc. Expands Its First-in-Class New York City Regional Life Science Cluster Franchise with the Strategic Acquisition of 219 East 42nd Street in Manhattan, Subject to a Leaseback
 
 Source: S&P Global Market Intelligence
Rows 1 through 20 of 386 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
This page contains press releases, which reflect information in Alexandria's possession or Alexandria's prediction of future events. Information appearing in such press releases is current only as of the date of each release, and shall not be considered "republished" at any later date.

Copyright 2019, © S&P Global Market Intelligence  Terms of Use